Evidence map›Paper›PMID 34946187›Full record

ArticleMicroorganisms2021

Comprehensive Contact Tracing, Testing and Sequencing Show Limited Transmission of SARS-CoV-2 between Children in Schools in Norway, August 2020 to May 2021.

Brita Askeland Winje, Trine Skogset Ofitserova, Ola Brønstad Brynildsrud, Margrethe Greve-Isdahl, Karoline Bragstad, Rikard Rykkvin, Olav Hungnes, Hilde Marie Lund, Karin Nygård, Hinta Meijerink and 1 more

Abstract read
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Measures implemented in the school setting to contain the COVID-19 pandemic.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Brita Askeland WinjeDepartment of Infection Control and Vaccine, Norwegian Institute of Public Health, 0213 Oslo, Norway.ORCID 0000-0003-2858-7248
Trine Skogset OfitserovaDepartment of Infection Control and Vaccine, Norwegian Institute of Public Health, 0213 Oslo, Norway.
Ola Brønstad BrynildsrudDepartment of Method Development and Analytics, Norwegian Institute of Public Health, 0213 Oslo, Norway.
Margrethe Greve-IsdahlDepartment of Infection Control and Vaccine, Norwegian Institute of Public Health, 0213 Oslo, Norway.
Karoline BragstadDepartment of Virology, Norwegian Institute of Public Health, 0213 Oslo, Norway.
Rikard RykkvinDepartment of Virology, Norwegian Institute of Public Health, 0213 Oslo, Norway.
Olav HungnesDepartment of Virology, Norwegian Institute of Public Health, 0213 Oslo, Norway.
Hilde Marie LundDepartment of Infection Control and Preparedness, Norwegian Institute of Public Health, 0213 Oslo, Norway.
Karin NygårdDepartment of Infection Control and Preparedness, Norwegian Institute of Public Health, 0213 Oslo, Norway.
Hinta MeijerinkDepartment of Infection Control and Vaccine, Norwegian Institute of Public Health, 0213 Oslo, Norway.
Lin Thorstensen BrandalDepartment of Infection Control and Preparedness, Norwegian Institute of Public Health, 0213 Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of children in the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in schools has been a topic of controversy. In this study among school contacts of SARS-CoV-2 positive children in 43 contact-investigations, we investigated SARS-CoV-2 transmission in Norway, August 2020-May 2021. All participants were tested twice within seven to ten days, using SARS-CoV-2 PCR on home-sampled saliva. Positive samples were whole genome sequenced. Among the 559 child contacts, eight tested positive (1.4%, 95% CI 0.62-2.80), with no significant difference between primary (1.0%, 95% CI 0.27-2.53) and secondary schools (2.6%, 95% CI 0.70-6.39),

Indexed as

childcontactCOVID-19infection prevention and controlSARS-CoV-2transmissionwhole genome sequencing

Identifiers

PMID34946187
PMCPMC8705768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.